CD274 and small cell lung carcinoma: Moreover, a preclinical model of immunocompetent SCLC in vivo observed that Chk1 inhibition, a protein kinase implicated in DSB repair, potentiated the antitumor effect of PD-L1 blockade and augmented cytotoxic T cell infiltration [133].